title: Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.
abstract: Previously, we reported on the in vitro antiviral activity of single-domain antibody fragments (VHHs) directed against poliovirus type 1. Five VHHs were found to neutralize poliovirus type 1 in an in vitro setting and showed 50% effective concentrations (EC50s) in the nanomolar range. In the present study, we further investigated the mechanism of action of these VHHs. All five VHHs interfere at multiple levels of the viral replication cycle, as they interfere both with attachment of the virus to cells and with viral uncoating. The latter effect is consistent with their ability to stabilize the poliovirus capsid, as observed in a ThermoFluor thermal shift assay, in which the virus is gradually heated and the temperature causing 50% of the RNA to be released from the capsid is determined, either in the presence or in the absence of the VHHs. The VHH-capsid interactions were also seen to induce aggregation of the virus-VHH complexes. However, this observation cannot yet be linked to their mechanism of action. Cryo-electron microscopy (cryo-EM) reconstructions of two VHHs in complex with poliovirus type 1 show no conformational changes of the capsid to explain this aggregation. On the other hand, these reconstructions do show that the binding sites of VHHs PVSP6A and PVSP29F overlap the binding site for the poliovirus receptor (CD155/PVR) and span interfaces that are altered during receptor-induced conformational changes associated with cell entry. This may explain the interference at the level of cell attachment of the virus as well as their effect on uncoating.
  
  
  OBJECTIVE
  The study describes the mechanism of neutralization and the capsid-stabilizing activity of five single-domain antibody fragments (VHHs) that have an in vitro neutralizing activity against poliovirus type 1. The results show that the VHHs interfere at multiple levels of the viral replication cycle (cell attachment and viral uncoating). These mechanisms are possibly shared by some conventional antibodies and may therefore provide some insight into the natural immune responses. Since the binding sites of two VHHs studied by cryo-EM are very similar to that of the receptor, the VHHs can be used as probes to study the authentic virus-cell interaction. The structures and conclusions in this study are original and raise interesting findings regarding virus-receptor interactions and the order of key events early in infection.
authors: Department of Pharmaceutical Biotechnology and Molecular Biology, Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium.
authors: Lise
authors: L
authors: Schotte
authors: Mike
authors: M
authors: Strauss
authors: Bert
authors: B
authors: Thys
authors: Hadewych
authors: H
authors: Halewyck
authors: David J
authors: DJ
authors: Filman
authors: Mihnea
authors: M
authors: Bostina
authors: James M
authors: JM
authors: Hogle
authors: Bart
authors: B
authors: Rombaut
mesh_terms: D000914:Antibodies, Viral / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology; D002213:Capsid / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D036022:Capsid Proteins / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D006801:Humans; D011051:Poliomyelitis / Q000821:virology*; D017955:Poliovirus / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D061905:Single-Domain Antibodies / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects; D057646:Virus Uncoating / Q000187:drug effects
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents; D036022:Capsid Proteins; D061905:Single-Domain Antibodies